Tofacitinib 5 MG
Sponsors
Pfizer, GlaxoSmithKline, Huashan Hospital, RenJi Hospital, Chinese SLE Treatment And Research Group
Conditions
Ankylosing SpondylitisArthritis, RheumatoidAxial SpondyloarthritisDermatomyositisEffect of DrugFrontal Fibrosing AlopeciaHealthyItch
Early Phase 1
Phase 1
Phase 2
Dose-Ranging Study Of Tofacitinib In Adults With Active Ankylosing Spondylitis
CompletedNCT01786668
Start: 2013-04-30End: 2015-03-31Updated: 2016-06-10
Tofacitinib as a GC Sparing Agent for Polymyalgia Rheumatica
CompletedNCT04799262
Start: 2021-01-01End: 2022-05-01Updated: 2022-09-15
Study to Evaluate Safety, Tolerability, and Efficacy of GS-5718 in Participants With Active Rheumatoid Arthritis Who Have an Inadequate Response to Disease-modifying Antirheumatic Drug(s) (bDMARDs) Treatment
WithdrawnNCT05165771
Start: 2022-07-31End: 2023-03-31Updated: 2022-05-18
Baricitinib in the Treatment of Refractory Axial Spondyloarthritis Patients: A Comparison With Tofacitinib
NCT06114407
Start: 2023-10-30End: 2024-12-30Target: 184Updated: 2023-12-21
Phase 3
Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Methotrexate
CompletedNCT03980483
Start: 2019-05-16End: 2022-08-16Updated: 2024-03-27
Comparison of Tofacitinib and Prednisolone in the Treatment of Active Takayasu's Arteritis
NCT05749666
Start: 2023-01-20End: 2025-07-20Target: 50Updated: 2023-03-01
Phase 4
Comparison of Adalimumab and Tofacitinib in the Treatment of Active Takayasu Arteritis
RecruitingNCT05151848
Start: 2022-01-05End: 2026-01-15Target: 100Updated: 2023-07-24
ToFAcitinib in Early Active Axial SpondyloarThritis:
RecruitingNCT06112665
Start: 2023-11-10End: 2026-06-30Target: 104Updated: 2024-11-26
3T Therapy in the Treatment of MDA5-positive Dermatomyositis
Enrolling by invitationNCT06438679
Start: 2024-03-19End: 2026-12-31Target: 133Updated: 2024-06-03
Major Adverse Cardiovascular Events (MACE) in Rheumatoid Arthritis Patient With Moderate to Severe Disease Activity Treated With Tofacitinib and Statins vs TNF Inhibitors: TOFSTAT CLINICAL TRIAL
RecruitingNCT07554820
Start: 2025-12-06End: 2026-09-30Target: 120Updated: 2026-04-28
Unknown Phase
Efficacy and Safety of Tofacitinib in Patients With Prurigo Nodularis
NCT06201715
Start: 2024-05-01End: 2025-12-30Target: 24Updated: 2024-04-01
Effectiveness and Safety of Tofacitinib in Patients With Recalcitrant Frontal Fibrosing Alopecia : A Pilot Study
CompletedNCT06202560
Start: 2023-11-29End: 2024-07-10Updated: 2025-05-30